Hemostemix Correlations

HMTXF Stock

USD 0.06 0 5.36%

The current 90-days correlation between Hemostemix and Hookipa Pharma is -0.03 (i.e., Good diversification). The correlation of Hemostemix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Hemostemix Correlation With Market

Average diversification

The correlation between Hemostemix and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hemostemix and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Hemostemix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hemostemix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hemostemix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hemostemix to buy it.

Moving against Hemostemix OTC Stock

0.83	PPERY	Bank Mandiri Persero	Pair Corr
0.73	BAC	Bank of America	Pair Corr
0.7	KB	KB Financial Group	Pair Corr
0.7	SHIP	Seanergy Maritime	Pair Corr
0.66	SHG	Shinhan Financial	Pair Corr
0.62	HL	Hecla Mining	Pair Corr
0.62	PHAR	Pharming Group NV	Pair Corr
0.6	PBCRY	Bank Central Asia	Pair Corr
0.59	68233JBP8	US68233JBP84	Pair Corr
0.58	IDN	Intellicheck Mobilisa	Pair Corr
0.56	NOEM	CO2 Energy Transition	Pair Corr
0.51	PPERF	Bank Mandiri Persero	Pair Corr
0.49	STAG	STAG Industrial	Pair Corr
0.46	PBCRF	PT Bank Central	Pair Corr
0.46	PTBRY	Bank Negara Indonesia	Pair Corr
0.38	HE	Hawaiian Electric	Pair Corr
0.38	CRRFY	Carrefour SA PK	Pair Corr
0.32	WF	Woori Financial Group	Pair Corr
0.8	CHACR	Crane Harbor Acquisition	Pair Corr
0.79	GM	General Motors	Pair Corr
0.77	REGN	Regeneron Pharmaceuticals	Pair Corr
0.76	RLMD	Relmada Therapeutics	Pair Corr
0.76	CX	Cemex SAB de Sell-off Trend	Pair Corr
0.72	APGE	Apogee Therapeutics,	Pair Corr
0.71	AKAM	Akamai Technologies	Pair Corr
0.67	DNLMY	Dunelm Group PLC	Pair Corr
0.6	KYOCF	Kyocera	Pair Corr
0.54	EGP	EastGroup Properties	Pair Corr

Related Correlations Analysis

	NYMXF	DVHGF	HOOK	LVCLF	IMUC	SRBCF	OXBOF	INTI	QPTFF	CLCS
NYMXF		0.0	-0.29	0.16	0.11	0.08	-0.04	0.05	0.0	-0.41	NYMXF
DVHGF	0.0		0.0	0.0	0.0	0.0	0.0	0.0	-1.0	0.0	DVHGF
HOOK	-0.29	0.0		0.33	-0.54	0.49	0.55	0.08	0.0	0.16	HOOK
LVCLF	0.16	0.0	0.33		-0.42	0.64	0.49	0.11	0.0	0.15	LVCLF
IMUC	0.11	0.0	-0.54	-0.42		-0.52	-0.67	-0.21	0.0	-0.05	IMUC
SRBCF	0.08	0.0	0.49	0.64	-0.52		0.73	0.19	0.0	0.06	SRBCF
OXBOF	-0.04	0.0	0.55	0.49	-0.67	0.73		0.28	0.0	-0.11	OXBOF
INTI	0.05	0.0	0.08	0.11	-0.21	0.19	0.28		0.0	-0.12	INTI
QPTFF	0.0	-1.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	QPTFF
CLCS	-0.41	0.0	0.16	0.15	-0.05	0.06	-0.11	-0.12	0.0		CLCS
	NYMXF	DVHGF	HOOK	LVCLF	IMUC	SRBCF	OXBOF	INTI	QPTFF	CLCS

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

OXBOF	+ 0.73	SRBCF
SRBCF	+ 0.64	LVCLF
OXBOF	+ 0.55	HOOK
SRBCF	+ 0.49	HOOK
OXBOF	+ 0.49	LVCLF
LVCLF	+ 0.33	HOOK

High negative correlations

QPTFF	- 1.0	DVHGF
OXBOF	- 0.67	IMUC
IMUC	- 0.54	HOOK
SRBCF	- 0.52	IMUC
IMUC	- 0.42	LVCLF
CLCS	- 0.41	NYMXF

Risk-Adjusted Indicators

There is a big difference between Hemostemix OTC Stock performing well and Hemostemix OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hemostemix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NYMXF	10.69	1.56	0.08	(0.53)	11.96	(14.95)	33.33	(25.00)	63.08
DVHGF	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HOOK	1.57	(0.06)	0.00	(1.92)	0.00	0.00	3.49	(3.30)	10.23
LVCLF	1.84	0.52	0.00	0.73	0.00	0.00	0.00	0.00	22.22
IMUC	16.78	5.68	0.13	(0.49)	15.72	(37.19)	79.07	(37.50)	189.28
SRBCF	149.28	87.65	0.00	(0.37)	0.00	0.00	0.00	(4.96)	5,000
OXBOF	6.91	(1.38)	0.00	0.43	0.00	0.00	0.00	(36.36)	144.00
INTI	4.89	0.15	0.01	0.19	6.21	(11.76)	14.00	(15.79)	68.18
QPTFF	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CLCS	4.45	0.58	0.04	(0.20)	5.47	(8.59)	12.50	(13.16)	37.78

Be your own money manager

Our tools can tell you how much better you can do entering a position in Hemostemix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital

All Next

Launch Module

Hemostemix Corporate Management

Elected by the shareholders, the Hemostemix's board of directors comprises two types of representatives: Hemostemix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hemostemix. The board's role is to monitor Hemostemix's management team and ensure that shareholders' interests are well served. Hemostemix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hemostemix's outside directors are responsible for providing unbiased perspectives on the board's policies.

BA BA	President, CoFounder	Profile
MD Sr	Chief Officer	Profile
Thomas CA	Pres Inc	Profile
Peter Pavlin	VP Operations	Profile
Cameron Cole	Head Relations	Profile
Christina CPA	Interim Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC